drug · antibody drug conjugate
patient view →raludotatug deruxtecan
Phase 3updated 2mo agoby Daiichi Sankyo Co Ltd🔗 ChEMBL
Phase 3community read0 votes
Antibody drug conjugate drug with a maximum clinical stage of Phase 2, with 1 investigational indication.
indications
indications
NSCLC
all catalysts(1)
phase 1 completion · 1
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that